everyone. Thanks, and morning, good
third XXXX updates discuss and to the provide call, our morning's our through the year to quarter. QX fourth around financial our this current expectations and color for full made guidance we've I'm walk results, For going
regional on a constant same of basis, on quarter sequential XXXX. impact XX.X% slightly Net will better net currency XXXX versus we relevant second revenue sales compares billion, second period our not Asia-Pacific from compared the to on a as have the consolidated selling were growth P&L growth call, $X.XXX Moving in in with versus forward, will constant XXXX in and constant days. my Overall, is a in increase commentary the reported a XXXX, or in adjusted than be an my be the constant And the did we XXXX XXXX. results revenue to unless otherwise statements of how were basis. noted, second and and quarter expectations and EMEA. material quarter. it same quarter the currency and were flat provided think and currency versus sales improvement Americas for Also, a we basis currency on of last XX.X% more period increase the about quarterly a and this that When I'll provide comparison
For Americas X.X% the or XXXX. versus up the quarter, increased XX.X%
by pressure We the region XX.X% X.X% and back improvement EMEA being that country year. U.S. versus variability factor. to continue We the XXXX, or in to expect with with trend EMEA a we grew XXXX. continued versus continue growing the through we X.X% within the did down this COVID quarter, XX.X% see half as or through see moved of
Asia-Pacific headwinds. versus Lastly, XXXX spite unexpected of some in or X.X% grew XX.X%
advance rollout has knee procurement China. the recent quarter by in impacted stable region second in and been inventory our in was of in the channel VBP. contraction volume-based or of quarters, the it categories While largely hip late within
COVID-XX a the growth. headwinds, including Japan. In in Despite region number of addition, these markets, we increase saw to and of a post continued resurgence
knee The categories. knees business business flat versus our increased XXXX. to or XX.X% In XX% XXXX. was Turning increased the X.X% global down or U.S., versus
normalized continue back in Still, we to encouraged joints, for procedural we of by sequential market and growth longer improvement strong bit be expected. a to Persona volumes in are the the large than While execution seeing Knee. ongoing path the team's is taking ROSA recovery momentum and most
In U.S., platinum X.X% and which down extremities. hip versus XX% and category by continued adoption grew increased and versus upper global solid versus sports for Strong the up favorable extremities and in X.X% Avenir XX.X% feedback trauma sports, or medicine, Our XXXX. XX.X% up increased for the hip CMFT Hip, accounts. XXXX. Complete driven The both XXXX, continues demand XX.X% business or growth gold or
the surgical see system One Signature registrations continue for planning shoulder strong We procedures. to of surgeon
Our grew or versus dental recovery in up fueled dental. XX.X% and X.X% by spine category 'XX,
contributions execution digital business. with and and better the implants products New in strong in dental commercial drove our quarter solutions growth from
category both launch revenues sequentially improvements versus ROSA reflects strong This 'XX. ongoing XXXX and demand Finally, We the partial QX quarter. from XXX.X% our the Robotics for knee units X.X% saw grew as the versus due or sold increased up of our application. to capital other well in purchases in as software
P&L. the to on Moving
of GAAP reported we per quarter, the earnings $X.XX. share diluted For
spending levels was quarter higher quarter. Our reported the reported GAAP a IPRD significantly in within up year-over-year revenue, investments loss in earnings GAAP of were GAAP share when of share compared earnings by XXXX. The normalized increase $X by diluted offset to driven second per the per and diluted
onetime margin of line share the of per not of On in than GAAP quarter the the charges that in XX.X% expected Adjusted some earnings of significantly elective as driven was addition, XXXX was second diluted pandemic prior higher In year, since $X.XX by procedures quarter second adjusted trough recovery did the repeat. with the basis, had an and XXXX. expectations. gross
year. first increased discretionary expenses infrastructure slight due operating spending the selling performance than improvement in stepped Improved sales innovation to operating offset and sequentially to quarter to commercial of and first and this our rate quarter versus margins, stable variable investments revenue higher the higher with The spending adjusted in through expectations. support line tax adjusted expenses up quarter a gross was margins more XX.X% $XXX R&D. of related Our million higher the XX.X% in to of over drive
Turning and to cash liquidity.
cash and robust $XXX.X second free quarter, we and flows cash million, just equivalents of cash were billion. and quarter $XXX.X $X million, was ended cash over the operating For the flow at with
deleveraging the on another million We continue quarter. the good repayments in third and make sheet make debt $XXX in to to balance progress expect
Moving to guidance. our financial
our outlook. As XXXX morning's have full noted press in updated year we this release,
COVID. half We range We year-to-date due procedure more but informed by that are financial potential view elective There not be performance the guidance. our recovery reflect tightening a assume COVID to linear our the no recovery may of worsening the and of our some that category. and and/or year, procedure volume in by underpin region XXXX to assumptions continues impact of key trends better product are guidance second of
to expect impact fourth seasonality third in to have years. observed prior as the also and we see We quarter
to of expecting year. to basis now improvement to guidance the XX.X% continue grow the reported compared QX in are points currency and versus impact of QX for we revenue fourth quarter. a we expect narrowing at constant about range, our over that full On for be to tailwind a the currency basis, the unchanged XX.X% of to XXXX, foreign XXXX, growth with With sequentially XXX
P&L. the to Turning
XX.X% be now full to XX% per of we our to the is in operating adjusted projection earnings share narrowed range and $X.XX have diluted to the adjusted for Our year. margin $X.XX,
Our balance QX the discretionary the updated our guidance expectation of consistent reflects performance growth through our improved operating to of and year. expenses the that date, EPS half with in second remained
expected to revenue While operating second overall operating second line decline stronger sequentially margins. half quarter, margins and versus half margins be third in sales expect are levels steady than investment operating lower to first quarter, the we the with in
Our flow XX.X% cash free adjusted in full for XX% tax of our range the to at year. rate is billion. million the projection estimates to unchanged $X.X remain $XXX And finally,
the market remainder summarize, We better expectations of second have slightly year. performance that our as to we To communicated on was you through through our we dynamics will continue QX the quarter. expectations and move in than to update financial you the
COVID pressure, some we I'll against momentum recovery more ability the that, in to of to Bryan. While execute turn backdrop. ongoing our have call over With back that the we and confidence anticipate the